The value of gut microbiota biomarkers in the diagnosis and treatment of viral infectious liver diseases
10.3760/cma.j.cn114452-20241218-00692
- VernacularTitle:肠道菌群标志物在病毒感染性肝病诊治中的价值
- Author:
Jianxiu YU
1
;
Shihai XUAN
;
Lipei WU
;
Honghong LI
;
Jian WU
Author Information
1. 南通大学附属东台医院检验科，东台 224200
- Publication Type:Journal Article
- Keywords:
Viral hepatitis;
Liver cirrhosis;
Hepatocellular carcinoma;
Liver failure;
Gut microbiota
- From:
Chinese Journal of Laboratory Medicine
2025;48(4):532-537
- CountryChina
- Language:Chinese
-
Abstract:
Viral hepatitis and related liver diseases are among the most significant global healthcare issues. Viral hepatitis not only directly affects liver function but also interacts with the gut microbiota through the gut-liver axis. Imbalance in the gut microbiota may be associated with the occurrence, development and prognosis of viral hepatitis and related liver diseases. Detection and analysis of the gut microbiota can help to comprehensively understand the health status of patients with viral hepatitis and related liver diseases, providing a basis for early diagnosis. Recovery of gut microbiota dysbiosis may help to alleviate liver inflammation and to improve liver function. Regulating the gut microbiota through gut microbiota transplantation, probiotics and prebiotics may be new strategies for treating viral hepatitis and related liver diseases. By analyzing the latest research progress of gut microbiota in viral hepatitis and related liver diseases, this article provides new methods for the diagnosis and treatment of viral hepatitis and related liver diseases.
